Our Team Is Our Advantage

Very few people truly understand the cannabis industry. Our team has decades of experience in the pre rec-legal industry and makes a difference.

Unlike many companies rushing into cannabis, through our experience and relationships, we are able to see opportunities others don’t.


Play Video
Play Video
Play Video
“We are at a historical turning point – the end of a prohibition.”


Very rarely, maybe once in a life time will anyone get an opportunity like this.The epicentre of this opportunity will be California and Chemistree has already established itself as a multifaceted player in that market.

Come join us in this growth story.


Sugar Leaf Case Study

We identify, re-organize and properly capitalize opportunities for sustainable growth. Read our case study on the turn around of SugarLeaf in Washington State.


Our Team, Our Advantage

Team Chemistree

We are proud to bring together a team of career cannabis experts. Click here to learn more and connect with us.

Karl Kottmeier

President and CEO

Sheldon Aberman

Chief Cannabis Officer and Director

Doug Ford

Chief Financial Officer

Significant Developments

Our Timeline

July 2018
December 2018
April 2019
Jun 2019
Jun 2020

Completion of $4.5 million financing

Enter into an agreement with Sugarleaf Farms to acquire the global brand and marketing rights to the Sugarleaf brand (outside of Washington State)
Completion of $10,830,000 debenture financing
Investment completed in Applied Cannabis Sciences Partnership. Filed three applications in New Jersey
Agreement to invest up to $1 million in Immunoflex biotech venture

Corporate Presentation

Industry knowledge

Chemistree will  provide a public vehicle entity to investors who are looking to invest in a company that is vertically integrated and approaches the Cannabis and CBD industry from a United States Market perspective.

Scroll to Top